Characterization of a Highly effective protein substrate for analysis of JAK2V617F Activity
- 30 November 2007
- journal article
- Published by Elsevier in Experimental Hematology
- Vol. 35 (11) , 1624-1632
- https://doi.org/10.1016/j.exphem.2007.07.003
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Erlotinib Effectively Inhibits JAK2V617F Activity and Polycythemia Vera Cell GrowthJournal of Biological Chemistry, 2007
- JAK2Exon 12 Mutations in Polycythemia Vera and Idiopathic ErythrocytosisNew England Journal of Medicine, 2007
- Molecular Pathogenesis and Therapy of Polycythemia Induced in Mice by JAK2 V617FPLOS ONE, 2006
- The Myeloproliferative DisordersNew England Journal of Medicine, 2006
- JAK2V617F: prevalence in a large Chinese hospital populationBlood, 2006
- MPLW515L Is a Novel Somatic Activating Mutation in Myelofibrosis with Myeloid MetaplasiaPLoS Medicine, 2006
- A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia veraNature, 2005
- EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib TherapyScience, 2004
- Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non–Small-Cell Lung Cancer to GefitinibNew England Journal of Medicine, 2004
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976